Immunogenicity of One-Dose Quadrivalent Human Papillomavirus Vaccine in Girls

There is now a lot of discussion on less than three doses for Human Papillomavirus (HPV) vaccination and, most probably, the immunity for an “aluminum-only” adjuvanted vaccine would be weaker. The HPV “late” L1 antigen seems to be not of good quality for the quadrivalent vaccine, and therefore L1 should not be a basis for argumentation in favor of a one-dose. We really doubt a “one-dose” proposal to be acceptable for HPV lesion control; certainly, it could be possible for lower response antigens like HPV 18, 11, and 6 with an aluminum-based formulation only. More importantly, the message sugge... Mehr ...